

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | COPI coating of Golgi vesicle (GO:0048205) | 5.01489183 |
| 2 | Golgi transport vesicle coating (GO:0048200) | 5.01489183 |
| 3 | purine deoxyribonucleotide catabolic process (GO:0009155) | 4.78992389 |
| 4 | nucleoside diphosphate catabolic process (GO:0009134) | 4.21483449 |
| 5 | pinocytosis (GO:0006907) | 4.21439770 |
| 6 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.19332385 |
| 7 | regulation of early endosome to late endosome transport (GO:2000641) | 4.12654905 |
| 8 | regulation of mitochondrial translation (GO:0070129) | 3.89695356 |
| 9 | positive regulation of lamellipodium organization (GO:1902745) | 3.88967500 |
| 10 | respiratory chain complex IV assembly (GO:0008535) | 3.88872249 |
| 11 | negative regulation of osteoblast proliferation (GO:0033689) | 3.78909707 |
| 12 | establishment of viral latency (GO:0019043) | 3.66825855 |
| 13 | ribosomal small subunit assembly (GO:0000028) | 3.63641442 |
| 14 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.59258000 |
| 15 | positive regulation of actin filament depolymerization (GO:0030836) | 3.54413167 |
| 16 | cotranslational protein targeting to membrane (GO:0006613) | 3.53093346 |
| 17 | protein targeting to ER (GO:0045047) | 3.52453965 |
| 18 | establishment of integrated proviral latency (GO:0075713) | 3.48114763 |
| 19 | NADPH regeneration (GO:0006740) | 3.45939393 |
| 20 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.44855008 |
| 21 | viral transcription (GO:0019083) | 3.43986095 |
| 22 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.43134189 |
| 23 | cytochrome complex assembly (GO:0017004) | 3.36350412 |
| 24 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.35129787 |
| 25 | protein localization to endosome (GO:0036010) | 3.34753375 |
| 26 | protein maturation by protein folding (GO:0022417) | 3.32776118 |
| 27 | positive regulation of lamellipodium assembly (GO:0010592) | 3.31395548 |
| 28 | translational termination (GO:0006415) | 3.29594983 |
| 29 | cullin deneddylation (GO:0010388) | 3.28923080 |
| 30 | protein localization to endoplasmic reticulum (GO:0070972) | 3.25229909 |
| 31 | deoxyribonucleotide catabolic process (GO:0009264) | 3.24152918 |
| 32 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.20345137 |
| 33 | glucose catabolic process (GO:0006007) | 3.19207854 |
| 34 | protein deneddylation (GO:0000338) | 3.17826599 |
| 35 | sequestering of actin monomers (GO:0042989) | 3.17779975 |
| 36 | deoxyribose phosphate catabolic process (GO:0046386) | 3.14695319 |
| 37 | GDP-mannose metabolic process (GO:0019673) | 3.09290573 |
| 38 | protein retention in ER lumen (GO:0006621) | 3.08240672 |
| 39 | translational elongation (GO:0006414) | 3.07779209 |
| 40 | regulation of superoxide anion generation (GO:0032928) | 3.05284758 |
| 41 | fibril organization (GO:0097435) | 3.01076995 |
| 42 | UV protection (GO:0009650) | 2.99944927 |
| 43 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.91067082 |
| 44 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.87629591 |
| 45 | negative regulation of cell killing (GO:0031342) | 2.87629591 |
| 46 | pentose metabolic process (GO:0019321) | 2.85719067 |
| 47 | amyloid precursor protein catabolic process (GO:0042987) | 2.85378889 |
| 48 | proline biosynthetic process (GO:0006561) | 2.84890624 |
| 49 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 2.82607595 |
| 50 | NIK/NF-kappaB signaling (GO:0038061) | 2.82579175 |
| 51 | barbed-end actin filament capping (GO:0051016) | 2.80161349 |
| 52 | positive regulation by symbiont of host defense response (GO:0052509) | 2.79559808 |
| 53 | modulation by symbiont of host defense response (GO:0052031) | 2.79559808 |
| 54 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.79559808 |
| 55 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.79559808 |
| 56 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.79559808 |
| 57 | modulation by symbiont of host immune response (GO:0052553) | 2.79559808 |
| 58 | viral life cycle (GO:0019058) | 2.79197225 |
| 59 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.78183358 |
| 60 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.78183358 |
| 61 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.77790618 |
| 62 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.77790618 |
| 63 | L-serine transport (GO:0015825) | 2.77785434 |
| 64 | extracellular fibril organization (GO:0043206) | 2.76818192 |
| 65 | protein complex biogenesis (GO:0070271) | 2.74906414 |
| 66 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.73957037 |
| 67 | regulation of chromatin binding (GO:0035561) | 2.69038445 |
| 68 | response to peptidoglycan (GO:0032494) | 2.68916800 |
| 69 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.66963850 |
| 70 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.66566579 |
| 71 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.66280030 |
| 72 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.66040679 |
| 73 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.65192823 |
| 74 | serine transport (GO:0032329) | 2.64668877 |
| 75 | translational initiation (GO:0006413) | 2.63815433 |
| 76 | cellular protein complex disassembly (GO:0043624) | 2.63489842 |
| 77 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.59498099 |
| 78 | NADH metabolic process (GO:0006734) | 2.59214111 |
| 79 | type B pancreatic cell proliferation (GO:0044342) | 2.57753315 |
| 80 | detection of bacterium (GO:0016045) | 2.57484604 |
| 81 | protein targeting to membrane (GO:0006612) | 2.56126342 |
| 82 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.55466565 |
| 83 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.55466565 |
| 84 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.55151960 |
| 85 | galactose catabolic process (GO:0019388) | 2.54648143 |
| 86 | negative regulation of gene silencing (GO:0060969) | 2.53742441 |
| 87 | peptidyl-histidine modification (GO:0018202) | 2.53737097 |
| 88 | de novo posttranslational protein folding (GO:0051084) | 2.53438024 |
| 89 | regulation of defense response to virus by virus (GO:0050690) | 2.52845524 |
| 90 | amino sugar catabolic process (GO:0046348) | 2.52785195 |
| 91 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.51981695 |
| 92 | negative regulation of phagocytosis (GO:0050765) | 2.51589498 |
| 93 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.51293205 |
| 94 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.51253484 |
| 95 | neutrophil activation involved in immune response (GO:0002283) | 2.50147799 |
| 96 | localization within membrane (GO:0051668) | 2.49928196 |
| 97 | regulation of protein heterodimerization activity (GO:0043497) | 2.48784381 |
| 98 | detection of other organism (GO:0098543) | 2.48551496 |
| 99 | formation of translation preinitiation complex (GO:0001731) | 2.48005647 |
| 100 | immunoglobulin mediated immune response (GO:0016064) | 2.46521769 |
| 101 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.46347264 |
| 102 | positive regulation of nuclease activity (GO:0032075) | 2.45813558 |
| 103 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.45703374 |
| 104 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.45323107 |
| 105 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.44888903 |
| 106 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.43384267 |
| 107 | negative regulation of ligase activity (GO:0051352) | 2.42148713 |
| 108 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.42148713 |
| 109 | viral protein processing (GO:0019082) | 2.41975121 |
| 110 | de novo protein folding (GO:0006458) | 2.41200335 |
| 111 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.40736317 |
| 112 | base-excision repair, AP site formation (GO:0006285) | 2.40348165 |
| 113 | virion assembly (GO:0019068) | 2.39874672 |
| 114 | negative regulation of cell size (GO:0045792) | 2.39293643 |
| 115 | modulation by virus of host process (GO:0019054) | 2.39115743 |
| 116 | ribosomal small subunit biogenesis (GO:0042274) | 2.37294935 |
| 117 | keratan sulfate catabolic process (GO:0042340) | 2.36848051 |
| 118 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.35683690 |
| 119 | protein complex disassembly (GO:0043241) | 2.35300255 |
| 120 | pentose-phosphate shunt (GO:0006098) | 2.35229350 |
| 121 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.34988492 |
| 122 | modulation by symbiont of host cellular process (GO:0044068) | 2.34868041 |
| 123 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.34323105 |
| 124 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.34323105 |
| 125 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.34281467 |
| 126 | stress fiber assembly (GO:0043149) | 2.33436380 |
| 127 | regulation of extracellular matrix disassembly (GO:0010715) | 2.31909264 |
| 128 | signal peptide processing (GO:0006465) | 2.31588851 |
| 129 | purine nucleoside diphosphate metabolic process (GO:0009135) | 2.31324864 |
| 130 | purine ribonucleoside diphosphate metabolic process (GO:0009179) | 2.31324864 |
| 131 | DNA demethylation (GO:0080111) | 2.30139097 |
| 132 | glycosphingolipid catabolic process (GO:0046479) | 2.29576154 |
| 133 | translation (GO:0006412) | 2.29081411 |
| 134 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.28397776 |
| 135 | mature B cell differentiation involved in immune response (GO:0002313) | 2.28370743 |
| 136 | nucleotide salvage (GO:0043173) | 2.27948725 |
| 137 | purine nucleotide salvage (GO:0032261) | 2.27892964 |
| 138 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.27485337 |
| 139 | lipopolysaccharide metabolic process (GO:0008653) | 2.26816002 |
| 140 | pyrimidine nucleoside salvage (GO:0043097) | 2.24241372 |
| 141 | pyrimidine-containing compound salvage (GO:0008655) | 2.24241372 |
| 142 | macromolecular complex disassembly (GO:0032984) | 2.23961464 |
| 143 | purine deoxyribonucleotide metabolic process (GO:0009151) | 2.23223913 |
| 144 | actin nucleation (GO:0045010) | 2.23204552 |
| 145 | regulation of necrotic cell death (GO:0010939) | 2.23077379 |
| 146 | cellular response to interleukin-4 (GO:0071353) | 2.23028286 |
| 147 | regulation of nuclease activity (GO:0032069) | 2.22397140 |
| 148 | tricarboxylic acid metabolic process (GO:0072350) | 2.21483655 |
| 149 | negative regulation of stress fiber assembly (GO:0051497) | 2.20739233 |
| 150 | hyaluronan catabolic process (GO:0030214) | 2.20609506 |
| 151 | pseudouridine synthesis (GO:0001522) | 2.20592496 |
| 152 | regulation of T cell tolerance induction (GO:0002664) | 2.20315305 |
| 153 | platelet aggregation (GO:0070527) | 2.20074880 |
| 154 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.19750097 |
| 155 | positive regulation of B cell differentiation (GO:0045579) | 2.19294675 |
| 156 | response to interferon-beta (GO:0035456) | 2.19158324 |
| 157 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.18124386 |
| 158 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.17804622 |
| 159 | morphogenesis of an endothelium (GO:0003159) | 2.16921323 |
| 160 | endothelial tube morphogenesis (GO:0061154) | 2.16921323 |
| 161 | metallo-sulfur cluster assembly (GO:0031163) | 2.16248664 |
| 162 | iron-sulfur cluster assembly (GO:0016226) | 2.16248664 |
| 163 | regulation of mitochondrial membrane potential (GO:0051881) | 2.16182034 |
| 164 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.15873018 |
| 165 | membrane raft organization (GO:0031579) | 2.15549227 |
| 166 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.15365155 |
| 167 | mitochondrial calcium ion transport (GO:0006851) | 2.14993661 |
| 168 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.14743094 |
| 169 | membrane protein intracellular domain proteolysis (GO:0031293) | 2.14394160 |
| 170 | oligosaccharide catabolic process (GO:0009313) | 2.14179899 |
| 171 | transferrin transport (GO:0033572) | 2.13270500 |
| 172 | cerebellar Purkinje cell layer development (GO:0021680) | 2.12346198 |
| 173 | negative regulation of microtubule polymerization (GO:0031115) | 2.10401953 |
| 174 | negative regulation of norepinephrine secretion (GO:0010700) | 2.09796436 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.31129673 |
| 2 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.58716112 |
| 3 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.51090225 |
| 4 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.43410492 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.40047067 |
| 6 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.36356348 |
| 7 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.35445812 |
| 8 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.35372935 |
| 9 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.34838287 |
| 10 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.28823023 |
| 11 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.27215175 |
| 12 | MYC_22102868_ChIP-Seq_BL_Human | 2.26854322 |
| 13 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.22940439 |
| 14 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.06392783 |
| 15 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.04854833 |
| 16 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.04053650 |
| 17 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.01664539 |
| 18 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.97314136 |
| 19 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.93994028 |
| 20 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.93555380 |
| 21 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.91495884 |
| 22 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.91222230 |
| 23 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.88562888 |
| 24 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.87942794 |
| 25 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.85810302 |
| 26 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.85033264 |
| 27 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.82753491 |
| 28 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.82549867 |
| 29 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81865921 |
| 30 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.73812244 |
| 31 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.73328257 |
| 32 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.72424283 |
| 33 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.71289062 |
| 34 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.71181536 |
| 35 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.70314960 |
| 36 | * CIITA_25753668_ChIP-Seq_RAJI_Human | 1.65585995 |
| 37 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.65257278 |
| 38 | MAF_26560356_Chip-Seq_TH1_Human | 1.62739804 |
| 39 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.59797214 |
| 40 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.59748849 |
| 41 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58132694 |
| 42 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.57444904 |
| 43 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.57308450 |
| 44 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.57300982 |
| 45 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.54744405 |
| 46 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.52680565 |
| 47 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.52139627 |
| 48 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.50830466 |
| 49 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.50706093 |
| 50 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.48051859 |
| 51 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.47654147 |
| 52 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 1.47071086 |
| 53 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.47006317 |
| 54 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46681749 |
| 55 | UTX_26944678_Chip-Seq_JUKART_Human | 1.44112958 |
| 56 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.43342421 |
| 57 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.42030165 |
| 58 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.40998336 |
| 59 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.40831647 |
| 60 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.38764174 |
| 61 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.38069438 |
| 62 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.37566929 |
| 63 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.36029475 |
| 64 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.34788716 |
| 65 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.33940706 |
| 66 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.33188359 |
| 67 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.32932786 |
| 68 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.32227629 |
| 69 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.30514676 |
| 70 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.30254222 |
| 71 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.29784687 |
| 72 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.29628700 |
| 73 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.28864142 |
| 74 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.28564699 |
| 75 | P68_20966046_ChIP-Seq_HELA_Human | 1.28523136 |
| 76 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.26877303 |
| 77 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.26609288 |
| 78 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.26328692 |
| 79 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.26046406 |
| 80 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.24470772 |
| 81 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.23561258 |
| 82 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.22470569 |
| 83 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.21672478 |
| 84 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.21093940 |
| 85 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.21086211 |
| 86 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.20923063 |
| 87 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.20217526 |
| 88 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.20102372 |
| 89 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.18651411 |
| 90 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.18137383 |
| 91 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.17771160 |
| 92 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16327964 |
| 93 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.16309012 |
| 94 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.16170332 |
| 95 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.16120389 |
| 96 | MAF_26560356_Chip-Seq_TH2_Human | 1.15682914 |
| 97 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15222276 |
| 98 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.14781364 |
| 99 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.14227046 |
| 100 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.13730336 |
| 101 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.13231287 |
| 102 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.12913198 |
| 103 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.12628230 |
| 104 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.12457092 |
| 105 | MYB_26560356_Chip-Seq_TH2_Human | 1.12031928 |
| 106 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12013435 |
| 107 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.11804708 |
| 108 | SPI1_23127762_ChIP-Seq_K562_Human | 1.11654192 |
| 109 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.10346426 |
| 110 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08470738 |
| 111 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.07478203 |
| 112 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.06966313 |
| 113 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.05922700 |
| 114 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.05291100 |
| 115 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.05075382 |
| 116 | * CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.04805254 |
| 117 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.04207949 |
| 118 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.03761239 |
| 119 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.03717886 |
| 120 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.03619036 |
| 121 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.03371737 |
| 122 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.03212294 |
| 123 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.01983073 |
| 124 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.01715318 |
| 125 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.00758153 |
| 126 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.99299044 |
| 127 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.99102866 |
| 128 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.98431944 |
| 129 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.98255540 |
| 130 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.97978512 |
| 131 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.96725048 |
| 132 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.96397003 |
| 133 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.95614945 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 3.99732779 |
| 2 | MP0001348_abnormal_lacrimal_gland | 3.92283705 |
| 3 | MP0008260_abnormal_autophagy | 3.33499970 |
| 4 | MP0003191_abnormal_cellular_cholesterol | 3.22546308 |
| 5 | MP0008438_abnormal_cutaneous_collagen | 2.80970853 |
| 6 | MP0004147_increased_porphyrin_level | 2.77896010 |
| 7 | MP0009840_abnormal_foam_cell | 2.71867625 |
| 8 | MP0005464_abnormal_platelet_physiology | 2.60773078 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 2.58308256 |
| 10 | MP0003705_abnormal_hypodermis_morpholog | 2.30540876 |
| 11 | MP0002876_abnormal_thyroid_physiology | 2.23784908 |
| 12 | MP0002933_joint_inflammation | 2.17530789 |
| 13 | MP0000013_abnormal_adipose_tissue | 2.16428903 |
| 14 | MP0005451_abnormal_body_composition | 2.13577427 |
| 15 | MP0009333_abnormal_splenocyte_physiolog | 2.09113401 |
| 16 | MP0005671_abnormal_response_to | 1.98792151 |
| 17 | MP0003172_abnormal_lysosome_physiology | 1.93542144 |
| 18 | MP0006054_spinal_hemorrhage | 1.77851020 |
| 19 | MP0002877_abnormal_melanocyte_morpholog | 1.72353205 |
| 20 | MP0000751_myopathy | 1.71999038 |
| 21 | MP0004858_abnormal_nervous_system | 1.69866425 |
| 22 | MP0003122_maternal_imprinting | 1.63048323 |
| 23 | MP0001835_abnormal_antigen_presentation | 1.60208531 |
| 24 | MP0003075_altered_response_to | 1.58402363 |
| 25 | MP0000685_abnormal_immune_system | 1.54866016 |
| 26 | MP0001851_eye_inflammation | 1.50353489 |
| 27 | MP0002837_dystrophic_cardiac_calcinosis | 1.47951535 |
| 28 | MP0000003_abnormal_adipose_tissue | 1.47642369 |
| 29 | MP0001958_emphysema | 1.46847142 |
| 30 | MP0004084_abnormal_cardiac_muscle | 1.46220620 |
| 31 | MP0003763_abnormal_thymus_physiology | 1.45005715 |
| 32 | MP0001853_heart_inflammation | 1.43932547 |
| 33 | MP0002909_abnormal_adrenal_gland | 1.40605989 |
| 34 | MP0002396_abnormal_hematopoietic_system | 1.40223483 |
| 35 | MP0005000_abnormal_immune_tolerance | 1.38076502 |
| 36 | MP0004947_skin_inflammation | 1.37111187 |
| 37 | MP0001299_abnormal_eye_distance/ | 1.36239630 |
| 38 | MP0003279_aneurysm | 1.35678248 |
| 39 | MP0005165_increased_susceptibility_to | 1.33016110 |
| 40 | MP0003866_abnormal_defecation | 1.32139831 |
| 41 | MP0010155_abnormal_intestine_physiology | 1.31468958 |
| 42 | MP0003303_peritoneal_inflammation | 1.31394572 |
| 43 | MP0002420_abnormal_adaptive_immunity | 1.29214177 |
| 44 | MP0000604_amyloidosis | 1.28292191 |
| 45 | MP0003300_gastrointestinal_ulcer | 1.27966690 |
| 46 | MP0000749_muscle_degeneration | 1.26956429 |
| 47 | MP0001845_abnormal_inflammatory_respons | 1.26891815 |
| 48 | MP0001819_abnormal_immune_cell | 1.26596113 |
| 49 | MP0003329_amyloid_beta_deposits | 1.25945274 |
| 50 | MP0000343_altered_response_to | 1.24301564 |
| 51 | MP0004272_abnormal_basement_membrane | 1.24201170 |
| 52 | MP0005257_abnormal_intraocular_pressure | 1.23723132 |
| 53 | MP0009278_abnormal_bone_marrow | 1.23462313 |
| 54 | MP0002452_abnormal_antigen_presenting | 1.21087450 |
| 55 | MP0002751_abnormal_autonomic_nervous | 1.21052411 |
| 56 | MP0005390_skeleton_phenotype | 1.19141395 |
| 57 | MP0005387_immune_system_phenotype | 1.14533209 |
| 58 | MP0001790_abnormal_immune_system | 1.14533209 |
| 59 | MP0003186_abnormal_redox_activity | 1.14305718 |
| 60 | MP0008469_abnormal_protein_level | 1.13301268 |
| 61 | MP0003123_paternal_imprinting | 1.12655039 |
| 62 | MP0002148_abnormal_hypersensitivity_rea | 1.11552310 |
| 63 | MP0002398_abnormal_bone_marrow | 1.11457264 |
| 64 | MP0001986_abnormal_taste_sensitivity | 1.11426515 |
| 65 | MP0004043_abnormal_pH_regulation | 1.10541390 |
| 66 | MP0001533_abnormal_skeleton_physiology | 1.10193983 |
| 67 | MP0000465_gastrointestinal_hemorrhage | 1.09876651 |
| 68 | MP0003448_altered_tumor_morphology | 1.07660421 |
| 69 | MP0002723_abnormal_immune_serum | 1.06592276 |
| 70 | MP0006082_CNS_inflammation | 1.03361627 |
| 71 | MP0002132_abnormal_respiratory_system | 1.03098018 |
| 72 | MP0003566_abnormal_cell_adhesion | 1.02177744 |
| 73 | MP0004808_abnormal_hematopoietic_stem | 1.01421137 |
| 74 | MP0000716_abnormal_immune_system | 1.01362775 |
| 75 | MP0000689_abnormal_spleen_morphology | 1.00330343 |
| 76 | MP0002405_respiratory_system_inflammati | 0.99983636 |
| 77 | MP0003436_decreased_susceptibility_to | 0.99436575 |
| 78 | MP0000703_abnormal_thymus_morphology | 0.98837789 |
| 79 | MP0002896_abnormal_bone_mineralization | 0.98458553 |
| 80 | MP0001800_abnormal_humoral_immune | 0.98327119 |
| 81 | MP0001661_extended_life_span | 0.97765530 |
| 82 | MP0002060_abnormal_skin_morphology | 0.95727050 |
| 83 | MP0004510_myositis | 0.94380495 |
| 84 | MP0002429_abnormal_blood_cell | 0.94347443 |
| 85 | MP0000490_abnormal_crypts_of | 0.93999840 |
| 86 | MP0008007_abnormal_cellular_replicative | 0.93585314 |
| 87 | MP0002653_abnormal_ependyma_morphology | 0.93405815 |
| 88 | MP0002419_abnormal_innate_immunity | 0.92565908 |
| 89 | MP0005025_abnormal_response_to | 0.92213468 |
| 90 | MP0001243_abnormal_dermal_layer | 0.91783206 |
| 91 | MP0000681_abnormal_thyroid_gland | 0.90274640 |
| 92 | MP0003183_abnormal_peptide_metabolism | 0.89644619 |
| 93 | MP0005501_abnormal_skin_physiology | 0.88860986 |
| 94 | MP0003724_increased_susceptibility_to | 0.88097448 |
| 95 | MP0002722_abnormal_immune_system | 0.87683365 |
| 96 | MP0001664_abnormal_digestion | 0.86970363 |
| 97 | MP0010030_abnormal_orbit_morphology | 0.85898276 |
| 98 | MP0004233_abnormal_muscle_weight | 0.84617924 |
| 99 | MP0000858_altered_metastatic_potential | 0.84582484 |
| 100 | MP0003221_abnormal_cardiomyocyte_apopto | 0.84511559 |
| 101 | MP0005623_abnormal_meninges_morphology | 0.83697403 |
| 102 | MP0009763_increased_sensitivity_to | 0.83415416 |
| 103 | MP0008932_abnormal_embryonic_tissue | 0.83389817 |
| 104 | MP0005310_abnormal_salivary_gland | 0.82941295 |
| 105 | MP0005275_abnormal_skin_tensile | 0.82834335 |
| 106 | MP0005166_decreased_susceptibility_to | 0.81777407 |
| 107 | MP0003453_abnormal_keratinocyte_physiol | 0.81617403 |
| 108 | MP0006036_abnormal_mitochondrial_physio | 0.80533251 |
| 109 | MP0004185_abnormal_adipocyte_glucose | 0.80379712 |
| 110 | MP0005023_abnormal_wound_healing | 0.80082811 |
| 111 | MP0004036_abnormal_muscle_relaxation | 0.79856065 |
| 112 | MP0000733_abnormal_muscle_development | 0.77561145 |
| 113 | MP0009764_decreased_sensitivity_to | 0.77485958 |
| 114 | MP0003634_abnormal_glial_cell | 0.77299451 |
| 115 | MP0009384_cardiac_valve_regurgitation | 0.76800728 |
| 116 | MP0005503_abnormal_tendon_morphology | 0.76290748 |
| 117 | MP0003091_abnormal_cell_migration | 0.75666936 |
| 118 | MP0001270_distended_abdomen | 0.75502170 |
| 119 | MP0009785_altered_susceptibility_to | 0.75460985 |
| 120 | MP0005397_hematopoietic_system_phenotyp | 0.74801867 |
| 121 | MP0001545_abnormal_hematopoietic_system | 0.74801867 |
| 122 | MP0005621_abnormal_cell_physiology | 0.74752510 |
| 123 | MP0002019_abnormal_tumor_incidence | 0.74476190 |
| 124 | MP0002089_abnormal_postnatal_growth/wei | 0.74317560 |
| 125 | MP0002166_altered_tumor_susceptibility | 0.73979766 |
| 126 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.73669213 |
| 127 | MP0002295_abnormal_pulmonary_circulatio | 0.73239186 |
| 128 | MP0000358_abnormal_cell_content/ | 0.72676409 |
| 129 | MP0000750_abnormal_muscle_regeneration | 0.71075993 |
| 130 | MP0001849_ear_inflammation | 0.70433883 |
| 131 | MP0001542_abnormal_bone_strength | 0.67878744 |
| 132 | MP0004134_abnormal_chest_morphology | 0.67724875 |
| 133 | MP0008789_abnormal_olfactory_epithelium | 0.67650182 |
| 134 | MP0003283_abnormal_digestive_organ | 0.67344153 |
| 135 | MP0000759_abnormal_skeletal_muscle | 0.67274428 |
| 136 | MP0003828_pulmonary_edema | 0.67110412 |
| 137 | MP0003795_abnormal_bone_structure | 0.66091816 |
| 138 | MP0009379_abnormal_foot_pigmentation | 0.65523575 |
| 139 | MP0001944_abnormal_pancreas_morphology | 0.63324571 |
| 140 | MP0000747_muscle_weakness | 0.61276464 |
| 141 | MP0000313_abnormal_cell_death | 0.60670146 |
| 142 | MP0002113_abnormal_skeleton_development | 0.58295077 |
| 143 | MP0003638_abnormal_response/metabolism_ | 0.57995724 |
| 144 | MP0002998_abnormal_bone_remodeling | 0.57511497 |
| 145 | MP0003121_genomic_imprinting | 0.57496186 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Aplastic anemia (HP:0001915) | 4.58701754 |
| 2 | Vacuolated lymphocytes (HP:0001922) | 4.34730241 |
| 3 | Deep palmar crease (HP:0006191) | 3.87993590 |
| 4 | Dysostosis multiplex (HP:0000943) | 3.79164267 |
| 5 | Oral leukoplakia (HP:0002745) | 3.53333284 |
| 6 | Cerebral aneurysm (HP:0004944) | 3.28811829 |
| 7 | Vertebral compression fractures (HP:0002953) | 3.22805960 |
| 8 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.10053116 |
| 9 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.10053116 |
| 10 | Abnormality of glycolipid metabolism (HP:0010969) | 3.10053116 |
| 11 | Cervical subluxation (HP:0003308) | 3.07236179 |
| 12 | Increased cerebral lipofuscin (HP:0011813) | 3.04924637 |
| 13 | Hepatocellular necrosis (HP:0001404) | 2.88905482 |
| 14 | Protrusio acetabuli (HP:0003179) | 2.82806658 |
| 15 | Progressive neurologic deterioration (HP:0002344) | 2.80658523 |
| 16 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.79259758 |
| 17 | Mucopolysacchariduria (HP:0008155) | 2.73118312 |
| 18 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.73118312 |
| 19 | Joint stiffness (HP:0001387) | 2.66859280 |
| 20 | Purpura (HP:0000979) | 2.65154919 |
| 21 | Ragged-red muscle fibers (HP:0003200) | 2.65046195 |
| 22 | IgM deficiency (HP:0002850) | 2.63364819 |
| 23 | Hepatosplenomegaly (HP:0001433) | 2.60932396 |
| 24 | Loss of speech (HP:0002371) | 2.60392461 |
| 25 | Prolonged neonatal jaundice (HP:0006579) | 2.59636130 |
| 26 | Abnormality of macrophages (HP:0004311) | 2.49971334 |
| 27 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.46506330 |
| 28 | Short nail (HP:0001799) | 2.46395106 |
| 29 | Recurrent bacterial skin infections (HP:0005406) | 2.45809712 |
| 30 | Cerebral hypomyelination (HP:0006808) | 2.42583073 |
| 31 | Testicular atrophy (HP:0000029) | 2.39454796 |
| 32 | Hypertensive crisis (HP:0100735) | 2.39379747 |
| 33 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.39220585 |
| 34 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.39220585 |
| 35 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.39220585 |
| 36 | Amyloidosis (HP:0011034) | 2.38785640 |
| 37 | Pheochromocytoma (HP:0002666) | 2.35572560 |
| 38 | Split foot (HP:0001839) | 2.34307312 |
| 39 | Entropion (HP:0000621) | 2.34026126 |
| 40 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.33623702 |
| 41 | Obstructive lung disease (HP:0006536) | 2.32549618 |
| 42 | Chronic obstructive pulmonary disease (HP:0006510) | 2.32549618 |
| 43 | Broad metatarsal (HP:0001783) | 2.28445013 |
| 44 | Hepatic necrosis (HP:0002605) | 2.28329708 |
| 45 | Ulnar deviation of the wrist (HP:0003049) | 2.26600951 |
| 46 | Microvesicular hepatic steatosis (HP:0001414) | 2.24730993 |
| 47 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.24638860 |
| 48 | Neuroendocrine neoplasm (HP:0100634) | 2.24563379 |
| 49 | Interstitial pulmonary disease (HP:0006530) | 2.18097572 |
| 50 | Mesangial abnormality (HP:0001966) | 2.16174512 |
| 51 | Distal lower limb muscle weakness (HP:0009053) | 2.16152439 |
| 52 | Rough bone trabeculation (HP:0100670) | 2.13732176 |
| 53 | Abnormal gallbladder physiology (HP:0012438) | 2.09927541 |
| 54 | Cholecystitis (HP:0001082) | 2.09927541 |
| 55 | Thrombocytosis (HP:0001894) | 2.08376399 |
| 56 | Myositis (HP:0100614) | 2.08032555 |
| 57 | Severe short stature (HP:0003510) | 2.07527283 |
| 58 | Petechiae (HP:0000967) | 2.05770525 |
| 59 | Stridor (HP:0010307) | 2.05731887 |
| 60 | Mediastinal lymphadenopathy (HP:0100721) | 2.05689116 |
| 61 | Rhabdomyolysis (HP:0003201) | 2.05657615 |
| 62 | Partial duplication of the phalanx of hand (HP:0009999) | 2.05495425 |
| 63 | Axonal loss (HP:0003447) | 2.05033966 |
| 64 | Aortic dissection (HP:0002647) | 2.04039396 |
| 65 | Dilatation of the ascending aorta (HP:0005111) | 2.03823128 |
| 66 | Premature rupture of membranes (HP:0001788) | 2.02774638 |
| 67 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.01258174 |
| 68 | Trismus (HP:0000211) | 1.99987677 |
| 69 | Partial duplication of thumb phalanx (HP:0009944) | 1.98666662 |
| 70 | Mitochondrial inheritance (HP:0001427) | 1.98537529 |
| 71 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.97603170 |
| 72 | Increased serum ferritin (HP:0003281) | 1.97470544 |
| 73 | Adducted thumb (HP:0001181) | 1.96051054 |
| 74 | Achilles tendon contracture (HP:0001771) | 1.95309642 |
| 75 | Ankle contracture (HP:0006466) | 1.94509769 |
| 76 | Asymmetric septal hypertrophy (HP:0001670) | 1.93170019 |
| 77 | Emotional lability (HP:0000712) | 1.91700651 |
| 78 | Hypoplasia of the odontoid process (HP:0003311) | 1.91526676 |
| 79 | Distal upper limb amyotrophy (HP:0007149) | 1.91486093 |
| 80 | Upper limb amyotrophy (HP:0009129) | 1.91486093 |
| 81 | Recurrent abscess formation (HP:0002722) | 1.91038741 |
| 82 | Long palpebral fissure (HP:0000637) | 1.90768810 |
| 83 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.90140060 |
| 84 | Generalized amyotrophy (HP:0003700) | 1.90001270 |
| 85 | Poor head control (HP:0002421) | 1.89814944 |
| 86 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.89395387 |
| 87 | Osteolytic defects of the hand bones (HP:0009699) | 1.89395387 |
| 88 | Increased IgM level (HP:0003496) | 1.88855270 |
| 89 | Limb-girdle muscle atrophy (HP:0003797) | 1.87999911 |
| 90 | Cardiomegaly (HP:0001640) | 1.87810099 |
| 91 | Myopathic facies (HP:0002058) | 1.86905849 |
| 92 | Hypoplasia of the pons (HP:0012110) | 1.86627144 |
| 93 | Gastrointestinal dysmotility (HP:0002579) | 1.86280830 |
| 94 | Epistaxis (HP:0000421) | 1.85502600 |
| 95 | Premature graying of hair (HP:0002216) | 1.85366605 |
| 96 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.84954294 |
| 97 | Abnormal protein glycosylation (HP:0012346) | 1.84644323 |
| 98 | Abnormal glycosylation (HP:0012345) | 1.84644323 |
| 99 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.84644323 |
| 100 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.84644323 |
| 101 | Hypercortisolism (HP:0001578) | 1.84608745 |
| 102 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.84399707 |
| 103 | Cellulitis (HP:0100658) | 1.83932977 |
| 104 | Striae distensae (HP:0001065) | 1.82055188 |
| 105 | Vertebral hypoplasia (HP:0008417) | 1.81773860 |
| 106 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 1.81773860 |
| 107 | Agammaglobulinemia (HP:0004432) | 1.81122664 |
| 108 | Abnormal trabecular bone morphology (HP:0100671) | 1.80974276 |
| 109 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.80685718 |
| 110 | Hypertriglyceridemia (HP:0002155) | 1.80076779 |
| 111 | Fragile skin (HP:0001030) | 1.80012254 |
| 112 | Recurrent bronchitis (HP:0002837) | 1.79894512 |
| 113 | Microretrognathia (HP:0000308) | 1.79385436 |
| 114 | Eczematoid dermatitis (HP:0000976) | 1.79384040 |
| 115 | Disproportionate short-trunk short stature (HP:0003521) | 1.78904228 |
| 116 | Blue sclerae (HP:0000592) | 1.78166059 |
| 117 | Respiratory failure (HP:0002878) | 1.78162620 |
| 118 | Abnormality of the Achilles tendon (HP:0005109) | 1.77750397 |
| 119 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.76923282 |
| 120 | Chronic otitis media (HP:0000389) | 1.75207646 |
| 121 | Abnormality of the umbilical cord (HP:0010881) | 1.74320324 |
| 122 | Abnormality of the calcaneus (HP:0008364) | 1.74218011 |
| 123 | Scapular winging (HP:0003691) | 1.73010378 |
| 124 | Distal lower limb amyotrophy (HP:0008944) | 1.72317000 |
| 125 | Agitation (HP:0000713) | 1.72113612 |
| 126 | Aortic aneurysm (HP:0004942) | 1.71884433 |
| 127 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.71084691 |
| 128 | Rimmed vacuoles (HP:0003805) | 1.70747597 |
| 129 | Generalized hyperpigmentation (HP:0007440) | 1.69798721 |
| 130 | Gingivitis (HP:0000230) | 1.69469558 |
| 131 | Hypergammaglobulinemia (HP:0010702) | 1.69410179 |
| 132 | Meningitis (HP:0001287) | 1.68962793 |
| 133 | Colitis (HP:0002583) | 1.68807140 |
| 134 | Abnormality of skull ossification (HP:0002703) | 1.68780118 |
| 135 | Gastrointestinal inflammation (HP:0004386) | 1.68542741 |
| 136 | Polygenic inheritance (HP:0010982) | 1.68417099 |
| 137 | Abnormality of the odontoid process (HP:0003310) | 1.68206548 |
| 138 | Atrophic scars (HP:0001075) | 1.68184438 |
| 139 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.68097019 |
| 140 | Abnormality of the nasal mucosa (HP:0000433) | 1.67868236 |
| 141 | Thoracic kyphosis (HP:0002942) | 1.67860044 |
| 142 | Gastrointestinal stroma tumor (HP:0100723) | 1.67730473 |
| 143 | Fatigue (HP:0012378) | 1.67376132 |
| 144 | Biconcave vertebral bodies (HP:0004586) | 1.67246624 |
| 145 | Recurrent skin infections (HP:0001581) | 1.66552257 |
| 146 | Coxa vara (HP:0002812) | 1.66449269 |
| 147 | Pulmonary fibrosis (HP:0002206) | 1.66345695 |
| 148 | Upper motor neuron abnormality (HP:0002127) | 1.66137363 |
| 149 | Growth hormone excess (HP:0000845) | 1.65812168 |
| 150 | Urticaria (HP:0001025) | 1.65568320 |
| 151 | Abnormality of the acetabulum (HP:0003170) | 1.65237169 |
| 152 | Myocardial infarction (HP:0001658) | 1.65096431 |
| 153 | Hand muscle atrophy (HP:0009130) | 1.64897566 |
| 154 | Abnormality of dentin (HP:0010299) | 1.64613247 |
| 155 | Long toe (HP:0010511) | 1.63855841 |
| 156 | Nonimmune hydrops fetalis (HP:0001790) | 1.62906237 |
| 157 | Gingival bleeding (HP:0000225) | 1.62874331 |
| 158 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.62792063 |
| 159 | Increased variability in muscle fiber diameter (HP:0003557) | 1.62646283 |
| 160 | Progressive muscle weakness (HP:0003323) | 1.62633629 |
| 161 | Congenital glaucoma (HP:0001087) | 1.61837725 |
| 162 | Platyspondyly (HP:0000926) | 1.61836079 |
| 163 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.61445823 |
| 164 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.61445823 |
| 165 | Systemic lupus erythematosus (HP:0002725) | 1.58869938 |
| 166 | Increased CSF lactate (HP:0002490) | 1.58752748 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TESK2 | 3.48811895 |
| 2 | TRIB3 | 3.42142591 |
| 3 | MAP2K2 | 3.29816482 |
| 4 | ERN1 | 3.21404402 |
| 5 | MAP3K10 | 3.11870372 |
| 6 | BRAF | 2.87312269 |
| 7 | CDC7 | 2.71437799 |
| 8 | TESK1 | 2.68270228 |
| 9 | TLK1 | 2.62518647 |
| 10 | NME2 | 2.45271883 |
| 11 | SMG1 | 2.36611296 |
| 12 | BLK | 2.30781076 |
| 13 | VRK2 | 2.28821636 |
| 14 | BUB1 | 2.25807701 |
| 15 | LIMK1 | 2.18611028 |
| 16 | PRPF4B | 2.04735461 |
| 17 | MAP4K1 | 2.04579198 |
| 18 | ZAP70 | 2.01827831 |
| 19 | IRAK3 | 1.95841836 |
| 20 | CAMKK2 | 1.91942374 |
| 21 | MAP3K12 | 1.87411019 |
| 22 | CDK19 | 1.84018822 |
| 23 | MAP3K11 | 1.82659772 |
| 24 | LRRK2 | 1.81462410 |
| 25 | KDR | 1.70769315 |
| 26 | PAK4 | 1.70490320 |
| 27 | ILK | 1.64187974 |
| 28 | RIPK1 | 1.59084950 |
| 29 | MYLK | 1.54372453 |
| 30 | PKN2 | 1.50312310 |
| 31 | SCYL2 | 1.47390717 |
| 32 | TAOK2 | 1.46129202 |
| 33 | DAPK3 | 1.40250678 |
| 34 | MAP3K3 | 1.40159461 |
| 35 | TTN | 1.39983928 |
| 36 | NEK1 | 1.38750887 |
| 37 | EEF2K | 1.38200891 |
| 38 | PRKD2 | 1.38001661 |
| 39 | TBK1 | 1.33977166 |
| 40 | TGFBR1 | 1.28178306 |
| 41 | PASK | 1.27950015 |
| 42 | TSSK6 | 1.24848409 |
| 43 | ABL2 | 1.24097273 |
| 44 | LMTK2 | 1.21507070 |
| 45 | EIF2AK1 | 1.19166097 |
| 46 | TGFBR2 | 1.13567639 |
| 47 | SIK1 | 1.12751522 |
| 48 | RIPK4 | 1.10107395 |
| 49 | KIT | 1.06848816 |
| 50 | UHMK1 | 1.05574130 |
| 51 | BTK | 1.04189468 |
| 52 | EPHB1 | 1.03133215 |
| 53 | JAK3 | 1.00682881 |
| 54 | MARK3 | 0.97829208 |
| 55 | DAPK1 | 0.95387922 |
| 56 | MAP3K8 | 0.92426274 |
| 57 | PDK2 | 0.92196757 |
| 58 | MOS | 0.90359537 |
| 59 | STK16 | 0.89685258 |
| 60 | MAP3K1 | 0.87290602 |
| 61 | MAPK15 | 0.86605411 |
| 62 | EPHA2 | 0.83348435 |
| 63 | WNK4 | 0.82263515 |
| 64 | IRAK4 | 0.82178228 |
| 65 | BRSK1 | 0.81658354 |
| 66 | CCNB1 | 0.80694585 |
| 67 | FES | 0.80120036 |
| 68 | CSF1R | 0.77760441 |
| 69 | FGFR4 | 0.74962919 |
| 70 | TYK2 | 0.73634999 |
| 71 | BCKDK | 0.72419217 |
| 72 | PAK1 | 0.71367334 |
| 73 | SIK3 | 0.70518297 |
| 74 | SYK | 0.70289394 |
| 75 | CDK14 | 0.69374037 |
| 76 | PRKD3 | 0.67587669 |
| 77 | ACVR1B | 0.66961303 |
| 78 | MAP2K1 | 0.66680582 |
| 79 | PRKG2 | 0.66434758 |
| 80 | PIM2 | 0.66286648 |
| 81 | MAP3K14 | 0.66232477 |
| 82 | LCK | 0.65966212 |
| 83 | PAK2 | 0.65496541 |
| 84 | TXK | 0.64187298 |
| 85 | STK10 | 0.64062543 |
| 86 | BRSK2 | 0.62938485 |
| 87 | NEK9 | 0.62655158 |
| 88 | DYRK1B | 0.61562636 |
| 89 | ITK | 0.61417743 |
| 90 | CAMKK1 | 0.61188166 |
| 91 | MAP3K13 | 0.60516420 |
| 92 | BMX | 0.59878246 |
| 93 | MAPK11 | 0.59060459 |
| 94 | TAOK1 | 0.58659945 |
| 95 | RPS6KA4 | 0.57837028 |
| 96 | PDPK1 | 0.57172916 |
| 97 | ROCK2 | 0.57053046 |
| 98 | MATK | 0.56817425 |
| 99 | CLK1 | 0.56294977 |
| 100 | FGR | 0.55236874 |
| 101 | AURKA | 0.54375088 |
| 102 | PRKD1 | 0.53396213 |
| 103 | IKBKB | 0.52059622 |
| 104 | PTK2 | 0.49855837 |
| 105 | PDGFRA | 0.49503957 |
| 106 | HIPK2 | 0.49424551 |
| 107 | LYN | 0.48270452 |
| 108 | IRAK2 | 0.47995504 |
| 109 | EIF2AK3 | 0.47367796 |
| 110 | RPS6KB2 | 0.47248099 |
| 111 | TNK2 | 0.46479038 |
| 112 | CDK18 | 0.46033410 |
| 113 | RPS6KA2 | 0.45527501 |
| 114 | ADRBK1 | 0.45010373 |
| 115 | NME1 | 0.43926437 |
| 116 | CDC42BPA | 0.42326859 |
| 117 | PDK1 | 0.42241754 |
| 118 | GRK6 | 0.41737390 |
| 119 | DDR2 | 0.41178009 |
| 120 | MARK2 | 0.41009637 |
| 121 | GRK5 | 0.40231425 |
| 122 | CASK | 0.40021411 |
| 123 | CDK15 | 0.39487338 |
| 124 | CDK7 | 0.39451274 |
| 125 | PAK3 | 0.38948047 |
| 126 | HCK | 0.38856815 |
| 127 | RPS6KL1 | 0.38655568 |
| 128 | RPS6KC1 | 0.38655568 |
| 129 | ARAF | 0.37690754 |
| 130 | ICK | 0.37316887 |
| 131 | CDK4 | 0.37251509 |
| 132 | CDK11A | 0.37199682 |
| 133 | CSK | 0.36671334 |
| 134 | CDK8 | 0.36113389 |
| 135 | MAPKAPK2 | 0.35879925 |
| 136 | MINK1 | 0.35852011 |
| 137 | VRK1 | 0.35387788 |
| 138 | MAP2K3 | 0.34588961 |
| 139 | PTK6 | 0.34392543 |
| 140 | MAPKAPK3 | 0.32774169 |
| 141 | IKBKE | 0.30765510 |
| 142 | PRKCD | 0.30661422 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 3.13614535 |
| 2 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 2.42213028 |
| 3 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.33225165 |
| 4 | Sulfur relay system_Homo sapiens_hsa04122 | 2.31652705 |
| 5 | Ribosome_Homo sapiens_hsa03010 | 2.30615099 |
| 6 | Protein export_Homo sapiens_hsa03060 | 2.29450221 |
| 7 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.16339255 |
| 8 | Proteasome_Homo sapiens_hsa03050 | 2.10027423 |
| 9 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.02743324 |
| 10 | Lysosome_Homo sapiens_hsa04142 | 1.95749975 |
| 11 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.92516902 |
| 12 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.85580299 |
| 13 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.82360710 |
| 14 | DNA replication_Homo sapiens_hsa03030 | 1.73669797 |
| 15 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.70812195 |
| 16 | Parkinsons disease_Homo sapiens_hsa05012 | 1.66648198 |
| 17 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.57879059 |
| 18 | Carbon metabolism_Homo sapiens_hsa01200 | 1.56516460 |
| 19 | Spliceosome_Homo sapiens_hsa03040 | 1.50859688 |
| 20 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.47351541 |
| 21 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.39325238 |
| 22 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.36041692 |
| 23 | Shigellosis_Homo sapiens_hsa05131 | 1.35958008 |
| 24 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.34181902 |
| 25 | Allograft rejection_Homo sapiens_hsa05330 | 1.33125095 |
| 26 | Mismatch repair_Homo sapiens_hsa03430 | 1.32238729 |
| 27 | Viral myocarditis_Homo sapiens_hsa05416 | 1.31852333 |
| 28 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.31184947 |
| 29 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.29651795 |
| 30 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.25784972 |
| 31 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.23652486 |
| 32 | Base excision repair_Homo sapiens_hsa03410 | 1.21927468 |
| 33 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.19253805 |
| 34 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.19119835 |
| 35 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.17815243 |
| 36 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.17585839 |
| 37 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.17218665 |
| 38 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.15323208 |
| 39 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.13006927 |
| 40 | Phagosome_Homo sapiens_hsa04145 | 1.10482788 |
| 41 | Legionellosis_Homo sapiens_hsa05134 | 1.05210774 |
| 42 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.04401013 |
| 43 | Alzheimers disease_Homo sapiens_hsa05010 | 1.00516250 |
| 44 | Bladder cancer_Homo sapiens_hsa05219 | 0.99195821 |
| 45 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.98893285 |
| 46 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.97555891 |
| 47 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.96371403 |
| 48 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.95712040 |
| 49 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.95682066 |
| 50 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.94094906 |
| 51 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.94066443 |
| 52 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.93785324 |
| 53 | Thyroid cancer_Homo sapiens_hsa05216 | 0.90459908 |
| 54 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.90439990 |
| 55 | Huntingtons disease_Homo sapiens_hsa05016 | 0.88439490 |
| 56 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.88400530 |
| 57 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.87920492 |
| 58 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.87430971 |
| 59 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.86662194 |
| 60 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.86634661 |
| 61 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.85015849 |
| 62 | Apoptosis_Homo sapiens_hsa04210 | 0.83816106 |
| 63 | Endocytosis_Homo sapiens_hsa04144 | 0.83319522 |
| 64 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.82427655 |
| 65 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.82282841 |
| 66 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.80862092 |
| 67 | Malaria_Homo sapiens_hsa05144 | 0.80027818 |
| 68 | Leishmaniasis_Homo sapiens_hsa05140 | 0.79322322 |
| 69 | Colorectal cancer_Homo sapiens_hsa05210 | 0.79154133 |
| 70 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.77957371 |
| 71 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.77509994 |
| 72 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.75081493 |
| 73 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.74185959 |
| 74 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.73813353 |
| 75 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.73804201 |
| 76 | Asthma_Homo sapiens_hsa05310 | 0.73240509 |
| 77 | Cell cycle_Homo sapiens_hsa04110 | 0.72267644 |
| 78 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.71332049 |
| 79 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.71015627 |
| 80 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.70460814 |
| 81 | Pertussis_Homo sapiens_hsa05133 | 0.69247413 |
| 82 | Influenza A_Homo sapiens_hsa05164 | 0.68838758 |
| 83 | Focal adhesion_Homo sapiens_hsa04510 | 0.68188977 |
| 84 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.68150386 |
| 85 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.67662423 |
| 86 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.67018821 |
| 87 | Tuberculosis_Homo sapiens_hsa05152 | 0.67000395 |
| 88 | Hepatitis B_Homo sapiens_hsa05161 | 0.65534696 |
| 89 | Hepatitis C_Homo sapiens_hsa05160 | 0.65431617 |
| 90 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.64703209 |
| 91 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.63823853 |
| 92 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.63701316 |
| 93 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.63600881 |
| 94 | RNA degradation_Homo sapiens_hsa03018 | 0.63415468 |
| 95 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.62822830 |
| 96 | HTLV-I infection_Homo sapiens_hsa05166 | 0.61352597 |
| 97 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.61092893 |
| 98 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.60073081 |
| 99 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.59797391 |
| 100 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.59761144 |
| 101 | Salmonella infection_Homo sapiens_hsa05132 | 0.59707914 |
| 102 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.58805425 |
| 103 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.58109737 |
| 104 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.57698110 |
| 105 | Glioma_Homo sapiens_hsa05214 | 0.57542990 |
| 106 | Endometrial cancer_Homo sapiens_hsa05213 | 0.57161738 |
| 107 | Gap junction_Homo sapiens_hsa04540 | 0.55978849 |
| 108 | Prion diseases_Homo sapiens_hsa05020 | 0.55900262 |
| 109 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.55478498 |
| 110 | Galactose metabolism_Homo sapiens_hsa00052 | 0.54856547 |
| 111 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.54217710 |
| 112 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.53832457 |
| 113 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.50709885 |
| 114 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.50269623 |
| 115 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.49756964 |
| 116 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.48242603 |
| 117 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.48196830 |
| 118 | Measles_Homo sapiens_hsa05162 | 0.48149855 |
| 119 | RNA transport_Homo sapiens_hsa03013 | 0.48102505 |
| 120 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.47401655 |
| 121 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.47076440 |
| 122 | Platelet activation_Homo sapiens_hsa04611 | 0.46355051 |
| 123 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.46306956 |
| 124 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.45824382 |
| 125 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.45777656 |
| 126 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.44917952 |
| 127 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.44542985 |
| 128 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.44041312 |
| 129 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.43493792 |
| 130 | Purine metabolism_Homo sapiens_hsa00230 | 0.42519868 |
| 131 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.39317871 |
| 132 | Amoebiasis_Homo sapiens_hsa05146 | 0.39303058 |
| 133 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.38987050 |
| 134 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.38862811 |
| 135 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.38301560 |
| 136 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.38200254 |
| 137 | Alcoholism_Homo sapiens_hsa05034 | 0.37747416 |
| 138 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.37713975 |
| 139 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.37078060 |
| 140 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.36033775 |

